학술논문
The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint
Document Type
Review Article
Author
Source
In The Lancet Regional Health - Europe June 2023 29
Subject
Language
ISSN
2666-7762